Linalool induces cell cycle arrest and apoptosis in HepG2 cells through oxidative stress generation and modulation of Ras/MAPK and Akt/mTOR pathways

RODENAK-KLADNIEW, BORIS; CASTRO, AGUSTINA; STÄRKEL, PETER; DE SAEGER, CHRISTINE; DE BRAVO, MARGARITA GARCÍA; CRESPO, ROSANA

LIFE SCIENCES

PERGAMON-ELSEVIER SCIENCE LTD

Año: 2018

0024-3205

Aims: Linalool is a plant-derived monoterpene with anticancer activity, however its mechanisms of action remain poorly understood. The aim of this work was to elucidate the anticancer mechanisms of action of linalool in hepatocellularcarcinoma (HCC) HepG2 cells.Main methods: Cell viability and proliferation were determined by WST-1 assay and BrdU incorporation, respectively. Cell cycle analysis was assessed through flow cytometry (FC) and western blot (WB). Apoptosis was determinedby caspase-3 activity, TUNEL assay and WB. Reactive oxygen species (ROS) and mitochondrial membrane potential (MMP) were analyzed by FC and fluorescence microscopy. Expression of Ras, MAPKs (ERK, JNK and p38) and Akt/mTOR pathways were evaluated by WB.Key findings: Linalool (0?2.5mM) dose-dependently inhibited cell proliferation by inducing G0/G1 cell cycle arrest,through Cdk4 and cyclin A downregulation, p21 and p27 upregulation, and apoptosis, characterized by MMP loss, caspase-3 activation, PARP cleavage and DNA fragmentation. Low concentrations of linalool (1.0mM)reduced membrane-bound Ras and Akt activity whereas higher amounts (2.0mM) triggered mTOR inhibition and ROS generation, in correlation with MAPKs activation and Akt phosphorylation. ROS scavenger N-acetyl-L-cysteine partially rescued HepG2 cell growth and prevented MPP depolarization, ERK and JNK activation. Moreover,specific ERK and Akt phosphorylation inhibitors potentiated linalool anti-cancer activity, pointing Akt and ERK activation as pro-survival mechanisms in response to higher concentrations of linalool.Significance: This report reveals that linalool induces G0/G1 arrest and apoptosis in HepG2 cells involving Ras,MAPKs and Akt/mTOR pathways and suggests that linalool is a promising anticancer agent for HCC therapy